Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BND vs GSK✓SelectedUSD · GSKBND vs GSK performance historyLatest closeAs of-0.13%11/13
Stock and ETF performance explorer

BND vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.5%
GSK return
+105.0%
Excess return
-87.5%
Maximum drawdown
-18.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%+0.5%-0.6%-0.1%
7D-1.4%+1.1%-2.6%-1.5%
30D+0.6%+6.3%-5.8%+0.3%
3M-1.6%+1.8%-3.4%-1.7%
6M-1.5%+1.7%-3.2%-1.7%
YTD-1.5%+6.5%-8.0%-1.8%
1Y-1.1%+9.5%-10.6%-1.5%
3Y+13.6%+65.3%-51.7%+11.0%
5Y-1.8%+43.7%-45.5%-4.0%
All+17.5%+105.0%-87.5%+14.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling